RPARP‐AS1 Targets miR‐10b‐5p to Influence Prognosis in Non‐Small Cell Lung Cancer and Inhibit Tumor Progression
Silencing RPARP‐AS1 targeted miR‐10b‐5p to induce NSCLC cell proliferation, migration, and invasion, leading to tumor progression and poor prognosis.